等待开盘 10-21 09:30:00 美东时间
+0.260
+1.26%
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $36 price target.
10-07 21:15
今日重点评级关注:Needham:上调爱美医疗评级至"买入",目标价14美元;高盛:维持Roivant Sciences"买入"评级,目标价从20美元升至24美元
09-19 09:18
J.P. Morgan upgraded Aveanna Healthcare (NASDAQ:AVAH) to Neutral from Underweight and raised its Dec. 26 price target to $10 from $6 on Thursday, noting a balanced risk-reward setup for the home healt...
09-19 00:20
JP Morgan analyst Benjamin Rossi assumes Surgery Partners (NASDAQ:SGRY) with a Neutral rating and announces Price Target of $27.
09-18 19:04
An announcement from Surgery Partners ( ($SGRY) ) is now available. On August 4...
08-07 05:51
Surgery Partners Inc. ( ($SGRY) ) has released its Q2 earnings. Here is a break...
08-06 12:27
Surgery Partners (NASDAQ:SGRY) affirms FY2025 sales outlook from $3.300 billion-$3.450 billion to $3.300 billion-$3.450 billion vs $3.376 billion estimate.
08-05 19:32
Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 26.87 percent. This is a 19.05 percent decrease over earnings of $0.21 per share from
08-05 19:31